Pfizer anti-smoking agent EU approval
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
European authorities approve Pfizer's novel smoking agent varenicline Sept. 26 under the trade name Champix. Varenicline was approved in the U.S. May 10 under the trade name Chantix (1Pharmaceutical Approvals Monthly May 2006, p. 5). Pfizer had sought to use the Champix name in the U.S. as well, but FDA review documents said the name was "overly fanciful and overstates the efficacy of the product" (2Pharmaceutical Approvals Monthly July 2006, p. 27)...